SLOT: Full Definition
What is Zepbound?
Zepbound is the brand name for tirzepatide when it is FDA-approved for chronic weight management. It is the same active medication as Mounjaro (which is branded for type 2 diabetes), simply marketed under a different name for the obesity indication. Zepbound is a once-weekly injectable that belongs to a newer class of metabolic medications called dual GIP/Glp 1 Agonists, meaning it stimulates two gut hormone receptors that influence appetite, blood sugar, and digestion.
Zepbound was approved by the FDA in late 2023 for adults with obesity, or with overweight plus a weight-related condition such as high blood pressure, sleep apnea, or insulin resistance. It is increasingly used at Modern Thyroid Clinic for women who have struggled with stubborn weight tied to thyroid disease, perimenopause, or insulin resistance — populations where standard "eat less, move more" rarely solves the underlying physiology.
How does Zepbound work?
Zepbound activates two receptors that influence metabolic hormones: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). Together, these signals:
- Slow gastric emptying, so food stays in the stomach longer and you feel full sooner
- Quiet "food noise" — the persistent thoughts about food many women describe
- Improve insulin sensitivity and lower fasting glucose
- Reduce appetite at the level of the brain
In clinical trials, average weight loss over about 16 months was approximately 18-22% of body weight at the highest dose — significantly more than older weight-loss medications.
When is Zepbound prescribed?
Zepbound is appropriate for adults with a BMI of 30 or higher, or BMI 27+ with at least one weight-related condition (insulin resistance, type 2 diabetes, hypertension, sleep apnea, fatty liver). It is not a cosmetic medication, and it is not appropriate during pregnancy or for people with a personal or family history of medullary thyroid cancer or MEN-2.
Patient considerations
The most common side effects are gastrointestinal — nausea, constipation, and reflux — particularly during dose increases. Most settle with time and with thoughtful escalation. More important: Zepbound is a long-term tool, not a quick fix. Many women regain weight when it is stopped abruptly without behavior, nutrition, and muscle-building scaffolding in place. At MTC, Zepbound is paired with protein-forward nutrition, resistance training, and thyroid optimization — because the goal is durable metabolic health, not a number on the scale. Decisions about whether Zepbound is right for you should always be made with a clinician who knows your full history.
Common symptoms
Common questions
Is Zepbound the same as Mounjaro?
Yes — chemically. Both Zepbound and Mounjaro contain tirzepatide as the active ingredient and are made by the same manufacturer. The difference is the FDA-approved indication. Mounjaro is approved for type 2 diabetes, while Zepbound is approved for chronic weight management in adults with obesity or weight-related conditions. Insurance coverage and pricing can differ depending on which name is prescribed and which diagnosis is documented. Clinically, the active medication, the dosing schedule, and the side-effect profile are identical.
Will I regain the weight if I stop Zepbound?
Many people do regain a meaningful portion of the weight if Zepbound is stopped without a clear plan. Obesity is a chronic, relapsing condition — like high blood pressure — and tirzepatide treats it while you are on it. At Modern Thyroid Clinic, we focus on building protein intake, strength training, sleep, and underlying thyroid and insulin health alongside the medication, so women have metabolic resilience whether they stay on Zepbound long-term or eventually taper. The plan should always be individualized with your clinician.
Can I take Zepbound if I have Hashimoto's or hypothyroidism?
Generally yes, with careful monitoring. Zepbound does not directly affect thyroid hormone production, but rapid weight loss can shift thyroid medication needs, so [tsh] and free hormones should be checked more frequently after starting. Women with a personal or family history of medullary thyroid cancer or MEN-2 should not use this medication. Many of our [hashimotos-thyroiditis] patients tolerate Zepbound well when their thyroid is properly optimized first — the combination often produces the breakthrough they could not achieve with thyroid medication alone.
Think you might be dealing with this?
Talk to a Modern Thyroid Clinic specialist about your symptoms, labs, and next steps.
Book a Discovery CallThis content is for educational purposes only and is not medical advice. Consult a licensed clinician for diagnosis and treatment. Content on this page does not create a doctor-patient relationship with Modern Thyroid Clinic.